• Enliven Therapeutics to Present at Two Upcoming Investor Conferences

    Источник: Nasdaq GlobeNewswire / 29 май 2024 16:05:00   America/New_York

    BOULDER, Colo., May 29, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced that management will present at the following investor conferences in June: 

    Jefferies Global Healthcare Conference
    Format: Fireside Chat
    Date: Wednesday, June 5
    Time: 8:30 a.m. ET

    Goldman Sachs Annual Global Healthcare Conference
    Format: Fireside Chat
    Date: Monday, June 10
    Time: 3:20 p.m. ET

    Both fireside chats will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at https://ir.enliventherapeutics.com/. Each webcast will be archived for a period of 30 days following the conclusion of the live event.

    About Enliven Therapeutics
    Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help people with cancer not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven’s discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in Boulder, Colorado.

    Contact
    Investors
    ir@enliventherapeutics.com

    Media
    media@enliventherapeutics.com


    Primary Logo

Опубликовать